🇺🇸 FDA

Drug profile · INN

coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredients: tozinameran and riltozinameran)

COMIRNATY RTU (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.1) PARTIAL CHANGE APPROVAL

Patents linked
0
News articles
0

Quick answer

coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredients: tozinameran and riltozinameran) (COMIRNATY RTU (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.1) PARTIAL CHANGE APPROVAL) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredients: tozinameran and riltozinameran)
Brand COMIRNATY RTU (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.1) PARTIAL CHANGE APPROVAL

Frequently asked questions

What is coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredients: tozinameran and riltozinameran)?

coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredients: tozinameran and riltozinameran) (COMIRNATY RTU (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.1) PARTIAL CHANGE APPROVAL) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredients: tozinameran and riltozinameran)?

COMIRNATY RTU (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.1) PARTIAL CHANGE APPROVAL is a marketed brand name for coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredients: tozinameran and riltozinameran). Check FDA Drugs@FDA for the current US label holder and prescribing information.